Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

ESC 2025 - Σημαντικές Πληροφορίες για τη Δυσλιπιδαιμία

EADV 2025 Congress Highlights: Advancing Dermatology Through Science & Innovation

Explore the latest scientific insights and clinical updates from the European Academy of Dermatology and Venereology (EADV) 2025 Congress held in Paris. This year’s sessions spotlighted transformative developments in the management of atopic dermatitis (AD), chronic spontaneous urticaria (CSU), and bullous pemphigoid, with a strong focus on real-world evidence, emerging biologics, and the role of artificial intelligence in dermatology.

EADV 2025 Congress Highlights: Advancing Dermatology Through Science & Innovation

Explore the latest scientific insights and clinical updates from the European Academy of Dermatology and Venereology (EADV) 2025 Congress held in Paris. This year’s sessions spotlighted transformative developments in the management of atopic dermatitis (AD), chronic spontaneous urticaria (CSU), and bullous pemphigoid, with a strong focus on real-world evidence, emerging biologics, and the role of artificial intelligence in dermatology.

EADV 2025 Congress Highlights: Advancing Dermatology Through Science & Innovation

Explore the latest scientific insights and clinical updates from the European Academy of Dermatology and Venereology (EADV) 2025 Congress held in Paris. This year’s sessions spotlighted transformative developments in the management of atopic dermatitis (AD), chronic spontaneous urticaria (CSU), and bullous pemphigoid, with a strong focus on real-world evidence, emerging biologics, and the role of artificial intelligence in dermatology.

Η Αθηροσκληρωτική Καρδιαγγειακή Νόσος είναι η κύρια αιτία θανάτου παγκοσμίως

Evolving asthma landscape: watch expert perspectives

Gain global clinical insights in four short expert-led videos 

Beyfortus® Real World Evidence

Fabry-kór: Kezelés és monitorozás

A Cerezyme® élmény

Prevent the Event

Despite major advances in our understanding of atherosclerosis, ASCVD remains the leading cause of death globally.1

Prevent the Event

Despite major advances in our understanding of atherosclerosis, ASCVD remains the leading cause of death globally.1

Prevent the Event

Despite major advances in our understanding of atherosclerosis, ASCVD remains the leading cause of death globally.1